Mode
Text Size
Log in / Sign up
N/A N=152 Randomized Single-blind Treatment

Evaluation of the Effectiveness and Safety of Diluted RADIESSE® in the Treatment of Décolleté Wrinkles

Décolleté Wrinkles

Enrolled (actual)
152
Serious AEs
1.3%
Results posted
Oct 2025
Primary outcome: Primary: Percentage of Responders on Merz Aesthetic Scale (MAS) Décolleté Wrinkles - at Rest at Week 24 — 71.2; 6.3 percentage of subjects

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Treatment with diluted Radiesse (Device)
Age
Adult, Older Adult · 30+ yrs
Sex
Female
Sponsor
Merz North America, Inc.
Primary completion
Sep 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Responders on Merz Aesthetic Scale (MAS) Décolleté Wrinkles - at Rest at Week 24
71.2; 6.3
SECONDARY
Percentage of Responders on MAS Décolleté Wrinkles - Dynamic at Week 24
65.8; 16.0
SECONDARY
Percentage of Subjects With Any Improvement on Investigator Global Aesthetic Improvement Scale (iGAIS) at Week 24
92.6
SECONDARY
Percentage of Subjects With Any Improvement on Subject Global Aesthetic Improvement Scale (sGAIS) at Week 24
87.4
SECONDARY
Number of Subjects With Treatment-emergent Adverse Events (TEAEs) Related to Radiesse
16; 0

Summary

Trial to confirm the effectiveness and demonstrate the safety of treatment with diluted Radiesse for correction of Décolleté Wrinkles.

Eligibility Criteria

Inclusion Criteria

  • Female between ≥ 30 and ≤ 65 years old at the time of the screening.
  • Subjects seeking improvement of décolleté wrinkles.

Exclusion Criteria

  • Any previous surgery, including plastic surgery or permanent surgical implant in the treatment area.
  • Previous treatment with collagen fillers, calcium hydroxylapatite, and/or long-lasting hyaluronic acid (HA) fillers in the décolleté, or with other HA fillers in the décolleté.
  • Previous treatment with botulinum toxin, ablative or fractional laser, microdermabrasion, microneedling, chemical peels, and/or non-invasive skin tightening in the décolleté.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05163353). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search